CAMBRIDGE, MA, Ketryx, the AI-powered compliance platform helping life sciences companies ship safer products faster, today announced a $39 million Series B round.
The round was led by Transformation Capital, with participation from existing investors including Lightspeed Venture Partners, MIT's E14 Fund, Ubiquity Ventures, and 53 Stations. This latest round brings the company's total funding to over $55 million, and Vinay Shah, Partner and Founding Team Member at Transformation Capital, will join Ketryx's board.
Ketryx transforms the product lifecycle of life science teams to deliver safer products, faster. Trusted by three of the world's top five medical device manufacturers, its AI-powered compliance platform overlays existing tools to automate documentation, create traceability, and accelerate release cycles-without disrupting existing workflows. Ketryx AI Agents cut manual work by 90 percent and close compliance gaps, elevating speed and quality across the entire product lifecycle.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.